Lilly

November 1, 2013

Alliance showcases shared commitment to type 1 diabetes community; kicks off activities for T1Day observance Nov. 1

Diabetes, Eli Lilly, Medical, Pharmaceuticals, Press Releases

MINNEAPOLIS and NEW YORK and INDIANAPOLIS, Nov. 1, 2013 /PRNewswire/ — News Highlights: Medtronic and Lilly Diabetes become first ever national presenting sponsors of the #JDRF Walk to Cure #Diabetes Medtronic, Lilly Diabetes help fund more than $500K for #T1D research through #JDRF Walk to Cure #Diabetes national sponsorship Medtronic, Lilly Diabetes’ #JDRF Walk to Cure #Diabetes national sponsorship announcement kicks off #T1Day […]

October 25, 2013

FDA Approves Addition to CIALIS® (tadalafil) Product Label

Eli Lilly, Medical, Pharmaceuticals, Press Releases

Study Data Shows Cialis 5 mg Initiated with Finasteride Provides Significantly Greater Improvements in Urinary Symptoms of Benign Prostatic Hyperplasia than Placebo with Finasteride INDIANAPOLIS, Oct. 25, 2013 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved a product label addition for CIALIS to include data from a 26-week study that showed […]

October 23, 2013

FDA Grants Lilly’s Ramucirumab Priority Review as a Potential Single-Agent Treatment for Advanced Gastric Cancer

Eli Lilly, Medical, Oncology, Pharmaceuticals, Press Releases

INDIANAPOLIS, Oct. 23, 2013 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has assigned Priority Review to the regulatory submission for ramucirumab (IMC-1121B) as a single-agent treatment for advanced gastric cancer following disease progression after initial chemotherapy. “We are very pleased that the FDA has […]

1 2